[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP0262118A1 - Verfahren und pilzstämme zur herstellung von pyranoson - Google Patents

Verfahren und pilzstämme zur herstellung von pyranoson

Info

Publication number
EP0262118A1
EP0262118A1 EP86900945A EP86900945A EP0262118A1 EP 0262118 A1 EP0262118 A1 EP 0262118A1 EP 86900945 A EP86900945 A EP 86900945A EP 86900945 A EP86900945 A EP 86900945A EP 0262118 A1 EP0262118 A1 EP 0262118A1
Authority
EP
European Patent Office
Prior art keywords
enzyme
pyranose
oxidase
glucosone
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP86900945A
Other languages
English (en)
French (fr)
Inventor
Kirston E. Koths
Robert F. Halenbeck
Peter M. Fernandes
David B. Ring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of EP0262118A1 publication Critical patent/EP0262118A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/58Aldonic, ketoaldonic or saccharic acids

Definitions

  • the present invention relates to methods and reagents for obtaining substantially pure products by enzymatic oxidation of the hydroxyl group at specific positions on certain pyranoses and structurally related compounds.
  • the invention concerns improved processes and reagents for making D-glucosone from D-glucose, D-xylosone from D-xylose, 5-keto-D-fructose from L-sorbose, or a mixture of 2-keto-D-gluconic acid and D-isoascorbic acid from delta-D-gluconolactone by reacting D-glucose, D-xylose, L-sorbose or delta-D-gluconolactone, respectively, with oxygen in aqueous solution at a pH between about 4 and 7 in the presence of a pyranose-2-oxidase enzyme.
  • the . invention also concerns pyranose-2-oxidase enzymes and fungi which are sources thereof.
  • the invention pertains to pyranosone-utilizing enzymes often found in pyranose-2-oxidase enzyme preparations obtained from certain fungal sources.
  • Glucose means D-glucose.
  • Glucosone means D-glucosone, also known as D-arabino-2-hexosulose. Pructose means D-fructose.
  • Xylose means D-xylose.
  • Xylosone means D-xylosone, also known as D-threo-2-pentasulose.
  • Xyulose means D-xyulose, also known as D-threo-2-pentulose.
  • Sorbose means L-sorbose.
  • 5-ketofructose means 5-keto-D-fructose, also known as D-threo-2,5-hexodiulose.
  • Delta-gluconolactone means delta-D-gluconolactone, also known as D-gluconic acid delta-lactone.
  • 2-ketogluconic acid means 2-keto-D-gluconic acid.
  • Isoascorbic acid means D-isoascorbic acid, also known as D-araboascorbic acid.
  • Pyranose means glucose, xylose, sorbose or delta-gluconolactone.
  • Pyranosone refers to glucosone or xylosone.
  • NRRL means the culture depository of the United States Department of Agriculture Northern Regional Research Laboratory in Peoria, Illinois, U.S.A. All NRRL deposits referred to herein were made under the terms of the Budapest Treaty on the International recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure and Regulations promulgated thereunder.
  • ATCC refers to the American Type Culture Collection culture depository located in Rockville, Maryland, U.S.A.
  • CMCC refers to the private culture collection of Cetus Corporation, 1400 Fifty-Third street, Emeryville, California, U.S.A.
  • Glucosone also has application in the production of mannitol and sorbitol.
  • European Application No. 83902934.5 filed August 16, 1983, pending, entitled “Process for the Production of Mannitol and Sorbitol", assigned to the assignee of the present application and incorporated herein by reference, describes a method of producing a mixture of mannitol and sorbitol having an exceptionally high mannitol-to-sorbitol ratio.
  • the mixture is prepared by reducing a solution of glucosone by catalytic hydrogenation, using a nickel catalyst in the presence of hydrogen.
  • substantially pure glucosone For production of a mannitol/sorbitol mixture suitable for use as a food sweetener, substantially pure glucosone must be used.
  • Glucosone being a relatively reactive compound, is also expected to be of use in other synthetic processes.
  • glucosone in aqueous solution at pH between about 4.5 and about 8.5 can be converted, by a novel pyranosone dehydratase enzyme described herein, to the antibiotic cortalcerone (2-hydroxy-6H-3-pyrone-2-carboxaldehyde hydrate, see Baute, et al., Phytochemistry 15., 1753-1755 (1976); Baute, et al., Phytochemistry 1£, 1895-1897 (1977)).
  • This pyranosone dehydratase enzyme first catalyses the dehydration of two of the equilibrium forms of glucosone present in aqueous solution, alpha-D-arabino-hexosulODvranose and/or beta-D-arabino-hexosulopyranose, to 2,4-dihydroxy-6-hydroxymethyl-6H-3-pyrone (and tautomers thereof) .
  • the equilibrium forms of glucosone which are substrates for the pyranosone dehydratase both have a keto group at position 2 in the pyranose ring, an R configuration at carbon 4 in the pyranose ring (the same stereochemical configuration as at carbon 4 in D-glucose) , and an axial hydrogen at carbon 3 (disposed with respect to the pyranose ring in the same way as the hydrogen at carbon 3 in D-glucose) .
  • This arrangement of keto oxygen at position 2, hydroxyl at position 4, and hydrogen at position 3 of a pyranose ring apparently provides the substrate specificity for catalytic dehydration (involving removal of the hydroxyl from position 4, and hydrogen from position 3) by pyranosone dehydratase.
  • a hydroxyl group at carbon 1 might also be required for substrate specificity.
  • the intermediate, 2,4-dihydroxy-6-hydroxymethyl-6H-3-pyrone is named by analogy with the formal name for cortalcerone, provided in Baute (1976) , supra.
  • the oxygen in the pyrone ring is at position 1, the keto-carbon at position 3 and the double bond between positions 4 and 5.
  • This intermediate has a highly strained structure. Its ring opens spontaneously in aqueous solution, forming -.- ⁇ .go ⁇ y-aldghydo-D- ⁇ lvcero-2,3- hexadiulose and tautomers thereof.
  • the compound, and its tautomers can recyclize between carbons 2 and 6 to form 3-deoxy-D- ⁇ L ⁇ er ⁇ -pentosulopyranose, 1-carboxaldehyde.
  • This compound which has the required steric arrangement for catalytic action by pyranosone dehydratase (an equitorial hydroxyl group on carbon 4, an axial hydrogen on carbon 3, and a keto oxygen on carbon 2) can be catalytically dehydrated by the enzyme to remove the hydroxyl from carbon 4 and one of the hydrogens from carbon 3, to produce cortalcerone, an antibiotic.
  • xylosone The other pyranosone which can be prepared as described herein is xylosone.
  • Xylosone can be reduced to xyulose by known methods, particularly by hydrogenation with molecular hydrogen in the presence of a heavy metal catalyst (e.g. palladium or carbon) , and by other methods, as described, for the reduction of glucosone by fructose, in U.S. patent 4,246,347 and Geigert, et al., Carbohyd. Res. HI, 159-162 (1983).
  • Xyulose can be fermented to ethanol by common yeasts (e.g. SaccharOTnyces cerevisiae) .
  • the methods and reagents of the present invention for conversion of xylose to xylosone, without subsequent significant enzymatic reaction of the xylosone, provide one step in a process for utilizing xylose from biomass to make ethanol.
  • the novel pyranosone dehydratase enzyme whose catalysis of the dehydration of glucosone to cortalcerone is described above and whose properties and isolation are further described below, also catalyzes the dehydration of xylosone in aqueous solution to compounds which would be expected to have antibiotic properties similar to cortalcerone, and potentially other properties which make them useful to the fungi which produce them, starting from xylose and passing through xylosone, under conditions of stress.
  • Xylosone exists in aqueous solution as an equilibrium mixture of alpha,D-£] ⁇ rj ⁇ o_-pentosuloplyranose and beta,D-ULL ⁇ -pentosulopyranose.
  • These compounds are the analogues of the alpha and beta anomers of the form of glucosone in solution on which the pyranosone dehydratase acts, as described above.
  • the xylosones differ from the glucosones by the absence of an hydroxymethyl group at carbon 5 in the pyranose ring.
  • the pyranosone dehydratase dehydrates one or both equilibrium forms of xylosone to 2,4-dihydroxy-6H-3-pyrone (and tautomers thereof) .
  • 2,4-dihydroxy-6H-3-pyrone is, like its analog derived from glucosone, a highly strained compound. It likely ring-opens to 4-deoxy-aldehydo-2_ ⁇ 3-pentadiulose and tautomers thereof.
  • the compound and any of the tautomers may be hydrated at the aldehyde group at position-1.
  • 4-dP ⁇ xy-aldehydo-2.3-pentadiulose lacks a sixth carbon atom, it cannot rearrange into a form with the steric requirement, -described above, for the action of pyranosone dehydratase. Consequently, the enzyme dehydrates xylosone only once.
  • tautomers or aldehyde-group hydrates of the compound might absorb strongly near 265 nm, but do not absorb significantly at any other wavelength between about 200 nm and about 300 nm.
  • 3-deoxy-D- ⁇ lycero- pentosulopyranose,l-carboxaldehyde (in any configuration, whether hydrated or not) does not absorb in the UV between about 200 nm and about 300 nm.
  • Cortalcerone however, has an absorption maximum only at about 230 nm, between 200 and 300 nm.
  • adding pyranosone dehydratase enzyme to an aqueous solution of pure xylosone results in increasing absorption at 265 nm and no absorbtion at 230 nm as the xylosone is dehydrated to the 6H-3-pyrone.
  • adding pyranosone dehydratase enzyme to an aqueous solution of pure glucosone results first in increasing absorption at 265 nm, as glucosone is dehydrated to the
  • 6H-3-pyrone and eventually in increasing absorption at 230 nm and decreasing absorption at 265 nm as 6H-3-pyrone rearranges to non-UV-absorbing 3-deoxy-D-glycero-pentosulopyranose,1 carboxaldehyde, which in turn is dehydrated by the enzyme to cortalcerone.
  • the 5-ketofructose obtained in substantially pure form from sorbose, with the methods and reagents provided in the present specification, can be converted to kojic acid, 3-oxykojic acid and 5-oxymaltol. See, e.g. Sato, et al., J. Agr. Biol. Chem. i , 877-878 (1967) and 23., 1606-1611 (1969).
  • Kojic acid itself is an antibiotic and can be converted to the flavor-enhancing additives maltol and ethyl altol. see Merck Index, 10th Edition, p. 764 (1983).
  • U.S. Patent 4,423,149 is assigned to the assignee of the present application and is incorporated herein by reference. Above-mentioned U.S. Patents 4,351,902 and 4,423,149 describe production of mixtures of 2-ketogluconic and isoascorbic acids from deltagluconolactone using glucose-2-oxidase enzyme preparations from Basidiomycgtes.
  • the prior art references in this area describe reactions using partially purified pyranose-2-oxidase (P20) derived from Polyporous obtusus. and carried out at a preferred pH of about 7.0. For a variety of reasons which will be explored below, these reaction methods inherently produce breakdown of the pyranosone products, reducing the yield and purity.
  • the prior art methods are also characterized generally by relatively short P20 half lives, due in part to a failure to control co-produced H2O2 levels adequately, as will be seen below.
  • a particular object of the invention is to provide a method of producing substantially pure glucosone for use in making high-purity food additive sugars such as fructose, mannitol and sorbitol.
  • Yet another object of the invention is to provide a relatively inexpensive and easily prepared P20 reagent which has enhanced stability under the reaction conditions employed in the method of the invention.
  • the method of the invention includes providing a P20 enzyme or enzyme preparation which is substantially free of measurable pyranosone-utilizing enzyme activity at a selected pH between about 4.4 and 7.0.
  • the P20 preparation is reacted with a pyranose substrate in the presence of an H2 ⁇ 2 ⁇ removing catalyst, such as catalase.
  • H2 ⁇ 2 ⁇ removing catalyst includes catalase which has been purified to remove substantially all glucose-1-oxidase activity.
  • the reaction is performed in the presence of oxygen at the selected pH between 4.4 and 6.0.
  • pyranosone dehydratase a major pyranosone-utilizing enzyme which has been identified is referred to herein as pyranosone dehydratase (PD) , so called for its ability to dehydrate pyranosones such as glucosone and xylosone.
  • This enzyme is present in partially purified P20 enzyme preparations obtained from P. obtusus.
  • the activity of the enzyme may be substantially eliminated, according to one aspect of the invention by (a) purifying the P20 preparation to remove PD; (b) heat-treating the P20 preparation to inactivate PD preferentially; and/or (c) carrying out the reaction at about pH 4.4.
  • the invention also contemplates selecting, as a source of P20, a fungal organism which is capable of converting glucose to glucosone, evidencing a P20 enzyme, but which is incapable of converting glucose or glucosone to cortalcerone, evidencing the absence of PD.
  • a fungal organism which is capable of converting glucose to glucosone, evidencing a P20 enzyme, but which is incapable of converting glucose or glucosone to cortalcerone, evidencing the absence of PD.
  • Two preferred organisms include Coriolus versi olQr and Lenzites betulinus.
  • a reagent composed of a solid support and surface-attached P20 and catalase molecules, at a P20/catalase activity ratio of between about 10-5 to 10-3.
  • the P20 is prepared to be free of substantially all pyranosone utilizing enzyme contaminants at a selected pH between about 4.4 and 6.0.
  • the invention also contemplates substantially pure P20 enzymes prepared from the above-mentioned sources, as well as cultures of fungi which produce enhanced amounts of P20 enzyme.
  • FIG. 1 compares the kinetics of heat inactivation of partially proteolyzed and intact forms of P20 and PD obtained from P. obtusus;
  • FIG. 2 shows the pH profile of P. obtusus P20 and PD;
  • FIG. 3 ⁇ is an absorbance profile, at 192 nm, of HPLC-fractionated reaction products obtained by reacting glucose, at pH 6.0, with a partially purified P. ohtusus P20 enzyme preparation;
  • FIG. 3fi is an absorbance profile, like that in FIG. 3 ⁇ , of reaction products produced by reacting glucose at pH 6.0 with a P. obtusus P20 enzyme which has been purified to remove glucosone-utilizing enzyme -11-
  • FIG. 3£ is an absorbance profile, like that in FIG. 3 ⁇ , of reaction products produced by reacting glucose at pH 6.0, with a P. obtusus P20 enzyme preparation which has been heat-treated to inactivate glucosone-utilizing enzyme contaminants;
  • FIG. 3fi is an absorbance profile, like that in FIG. 1A, of reaction products produced by reacting glucose, at pH 4.4, with the P20 enzyme preparation of FIG. ⁇ ;
  • FIG. 3_£ is an absorbance profile, like that shown in FIG. 3&, where the reaction described in FIG. 32. was performed at pH 4.4;
  • FIG. 4 illustrates, in flow-diagram form, procedures used in providing a P20 enzyme in accordance with the invention.
  • FIG. 5 shows an absorbance profile, at 192nm, of HPLC-fractionated reaction products obtained by reacting glucose, at pH 5.0, with purified P. obtusus P20 in an unbuffered reaction medium.
  • the invention includes providing a P20 enzyme, or enzyme preparation which is substantially free of pyranosone-utilizing enzyme contaminants which are measurably active at a selected pH between about 4.4 and 7.0.
  • the P20 enzyme may be used in forming a reagent which also includes an H2 ⁇ 2-decomposing catalyst, such as catalase, at a P20/catalase activity ratio of less than about 10"3 f i.e., an H2O2 concentration of less than about 10 ⁇ 3 M.
  • the enzyme, or enzyme reagent is reacted with a pyranose substrate in the presence of oxygen, at the selected pH to produce the corresponding, substantially pure product glucosone, xylosone, 5-ketofructose or mixture of 2-ketogluconic acid and isoascorbic acid.
  • Preferred substrates are glucose and xylose; most perferred is glucose.
  • the reaction may be pH stable, even in an unbuffered reaction medium. Details of the invention ill be described below with particular reference to methods for providing a P20 enzyme, for producing a reagent containing the enzyme and an H2 ⁇ 2-decomposing catalyst, and to reaction methods using the enzyme to produce substantially pure pyranosones, particularly glucosone.
  • pyranose-2-oxidase designates an enzyme capable of catalyzing the conversion, in aqueous solution with oxygen as co-reactant and hydrogen peroxide as co-product, of the hydroxyl group at the second carbon position (in the cases of glucose, xylose and deltagluconolactone) or the fifth carbon position (in the case of sorbose) of a pyranose to a keto group.
  • the enzyme's preferred substrate is glucose, which is converted to glucosone; but the enzyme also is active in converting xylose to xylosone, sorbose to 5-ketofructose and delta-gluconolactone to a mixture of 2-ketogluconic and isoascorbic acids.
  • Enzymes displaying such pyranose-2-oxidase activity may be obtained from a variety of microorganisms, molusca and red algae, as reported in the above cited U.S. Patent No. 4,246,347.
  • the preferred sources of the enzyme are the white-rot fungi of the BasidioiT.ycf-t.__s class, including Polyporus obtusus. Coriolus vprsicolor. and Lenzi es betUlinUS organisms, expecially P. obtusus.
  • These fungal organisms produce P20 enzymes having a preferred substrate specificity for glucose and an additional substrate specificity for sorbose, xylose and delta-gluconolactone.
  • the amount of pyranose-2-oxidase enzyme produced by the selected organism may be increased by mutation and selection techniques.
  • cells which have been prescreened for ability to produce relatively high P20 levels are exposed to a mutagenic agent, such as ultraviolet light, at a preselected level.
  • a mutagenic agent such as ultraviolet light
  • the cells are individually selected for increased P20 activity.
  • the mutation/selection procedure may be repeated to yield still higher-producing strains.
  • Example I below details a mutation/selection protocol used to produce a P. obtusus strain which produces P20 at a level which is about 5 times that of the unmutated P. obtusus cells prior to the selection procedure.
  • a P20 enzyme preparation containing partially purified P20 is prepared by disrupting- cells of the selected organism, and removing insoluble cell material by centrifugation. Further enzyme purification is achieved by adding to the supernatant, an agent which produces precipitation of selected supernatant proteins.
  • an agent which produces precipitation of selected supernatant proteins Exemplary protein-precipitating agents including salts, such as ammonium sulfate, solvents, such as polyethylene glycol, and strong acids.
  • the agent may be added at a single concentration, or in a series of increasing concentrations.
  • the precipitated proteins, which may include P20, are removed by centrifugation or filtration.
  • the P20 enzyme derived from P. obtusus and L * . hPt ⁇ i inus are preferably fractionated by precipitating the enzymes by the addition of polyethylene glycol.
  • Ammonium sulfate precipitation of the Ct yersicolPr P20 enzyme is preferred.
  • the enzyme precipitates may be resuspended in a buffer, incubated, and recentrifuged to remove insoluble proteins remaining in the resuspended enzyme fraction.
  • partially purified P20 enzyme preparations obtained from P. -obtusus have been reported in the prior art. Janssen and Ruelius (1968) and U.S. Patents 4,246,347; 4,351,902; and 4,423,149, SUS ⁇ A. These patents disclose a partially purified pyranose-2-oxidase fraction obtained from P.- obtusus. substantially according to the purification steps outlined above.
  • the enzyme preparation is advantageous in that P.
  • obtusus is known to produce relatively high levels of P20, and the enzyme can be obtained in large quantity from fermenting cells.
  • the steps leading to the partial enzyme purification can be carried out in commercial-scale quantities at relatively low cost, since only low-speed centrifugation steps are involved.
  • a variety of studies in which the above partially purified P. obtusus P20 was used to convert glucose to glucosone have shown that the glucosone produced may be contaminated to a substantial degree with by-products.
  • a partially purified P. obtusus P20 enzyme was reacted with a solution of pure glucose in a 0.1M sodium phosphate buffer, pH 6.0 in the presence of oxygen.
  • H2O2 generated in the reaction was decomposed by purified catalase also added to the reaction medium.
  • the glucose was completely used up ⁇ after a 2 hour reaction time at 24°C. However, the reaction was carried out for 6 hours at room temperature, to accentuate glucosone conversion or degradation reactions which contribute to reaction impurities.
  • the pH of the buffered reaction medium remained constant over the reaction period.
  • the products were analyzed by high performance liquid chromatography (HPLC) as described in Example II.
  • HPLC high performance liquid chromatography
  • the eluate from the column was monitored at 192 nm, where both glucosone (which absorbs strongly below 200 nm) and by-products (which absorb strongly about 230 nm) , are detectable.
  • the absorbance profile of the reaction products seen in FIG. 3 ⁇ , shows a peak which co-elutes with authentic glucosone and a major peak representing non-glucosone by-products.
  • the relatively high ratio of by-products to glucosone observed is somewhat exaggerated over what would be observed in an optimal-condition reaction, due to the extended time period of the reaction as noted above.
  • An important feature of the present invention is the finding that a major part of the non-glucosone by-products observed in an enzymatic glucosone-production reaction is due to the presence in the P20 enzyme preparation of one or more pyranosone-utilizing enzyme contaminants.
  • Studies have led to the identification of one major, and perhaps sole, pyranosone-utilizing enzyme contaminant in P20 preparations from the fungal source, P. obtusus.
  • the contaminating enzyme functions to dehydrate pyranosones, and accordingly has been designated "pyranosone dehydratase.”
  • pyranosone dehydratase Of particular interest is the action of this enzyme on glucosone.
  • Initial enzymatic dehydration of glucosone produces an unstable intermediate which has an absorption peak at about 265 nm.
  • the intermediate then rearranges to a stable pyranosone intermediate which is further enzymatically dehydrated, by the same enzyme, to form the " antibiotic cortalcerone, as discussed above.
  • the PD enzyme acts also with xylosone to produce a product which also absorbs with a peak near 265 nm.
  • This product is the analog, (lacking a hydroxymethyl group at position 5 on the pyrone ring) of the first intermediate formed from glucosone by the PD enzyme.
  • xylosone product intermediate may rearrange by ring-opening. However, because it has six carbon atoms, the ring-opened form of the intermediate from glucosone can undergo ring closure to a form with the steric requirements for the PD enzyme act (i.e. dehydrate) again, resulting in cortalcerone.
  • the straight-chain form of the xylosone-derived intermediate having 5 carbons, cannot recyclize to a form that can be acted on further by the PD enzyme.
  • the product of PD action on xylosone may also be an antibiotic.
  • the role of P20 is some organisms might also be to provide xylosone for subsequent dehydration with PD to provide an antibiotic for defensive purposes.
  • the method of the invention comprises, in part, providing a P20 enzyme which is substantially free of pyranosone-utilizing enzyme contaminants which have measurable activity at a selected pH between about 4.4 and 7.0.
  • a first step in providing the enzyme involves selecting a suitable P20 source.
  • Preferred P20 sources include microorganisms, and particularly fungal organisms, which can be cultured in relatively large quantities in a relatively short time period.
  • a microorganism, such as a fungus, which produces P20 can be identified readily by the ability of the cells, when broken, to convert glucose to glucosone, as determined, for example, by the reaction of glucosone with triphenyltetrazolium chloride (TTC) to give a strongly colored solution.
  • TTC triphenyltetrazolium chloride
  • a parental (unmutated) strain of P. obtusus was found to produce between about 200 and 500 enzyme units per liter of fungal culture after a ten day culture period.
  • Parental strains of C. versicolor and L. betulinus each produced between about 50 and 100 units per liter of fungal culture after a 7-day culture period.
  • the conversion of glucosone to cortalcerone can be monitored spectrophotometrically by following the reaction at the cortalcerone absorption peak at about 230nm, or at 265 nm, where an intermediate between glucosone and cortalcerone produced by PD from glucosone absorbs.
  • the disappearance of glucosone as monitored may be used to screen for PD activity, and more generally, for glucosone-utilizing enzyme activity.
  • Bas.diomycetes listed above which were found to produce P20, only P. obtusus showed measurable PD activity.
  • the above selection procedure is thus seen to identify two general categories of P20 producing organisms: one having the ability to convert glucose to glucosone and glucose or glucosone to cortalcerone, the latter reaction evidencing the presence of PD, and a second group capable of converting glucose to glucosone, but incapable of further metabolizing glucosone to cortalcerone.
  • These screening procedures could also be carried out using xylose and xylosone in place of glucose and glucosone, as xylosone can also be assayed using the TTC assay and is also dehydrated by PD to a spectrophotometrically active product, which absorbs strongly at about 260 nm.
  • the invention further contemplates providing a P20 enzyme which is substantially free of all measurable glucosone-utilizing enzyme activity at a selected pH between about 4.4 and 7.0. Initially a partially purified P20 preparation is obtained. Novel procedures for freeing the P20 enzyme preparation of pyranosone-utilizing enzyme activity at such selected pH generally include one of the following procedures:
  • the P20 enzyme is purified to remove substantially all pyranosone-utilizing enzymes, and in particular PD, which are active at a pH of about 6.0 or below;
  • the P20 enzyme is heat-treated to eliminate substantially all pyranosone-utilizing enzyme activity at a pH below about 6.0;
  • the P20 enzyme is utilized at a pH at or near about pH 4.4.
  • ion-exchange chromatography preferably carried out by ion-exchange chromatography.
  • the chromatographic separation can be monitored readily by assaying the eluted fractions for both P20 and PD activity.
  • the eluted samples are preferably assayed at a maximum pH of about 6.5.
  • the eluted samples showing highest P20 activity are combined, and where necessary, further separated from PD activity by molecular-sieve chromatography.
  • the reaction scheme used to purify P. obtusus P20 substantially to homogeneity is detailed in Example III below.
  • Example IV gives details of experimental procedures used and results obtained, with reference to FIG. 3£.
  • the glucosone produced after a six hour incubation period at pH 6.0, is substantially free of by-products, showing that most, if not all, glucosone breakdown at pH 6.0 is attributable to enzymatic breakdown.
  • Heat-treating the P20 enzyme preparation to inactivate pyranosone-utilizing enzyme contaminants, as in procedure (b) may be preferred where the P20 is substantially more heat-stable than pyranosone-utilizing enzyme contaminants. Heat inactivation can be performed relatively simply and inexpensively by comparison with chromatographic purification techniques. In assessing the heat stability of the P20 enzyme, the effect of partial proteolysis and pH should be considered. For example, studies on the heat stability of P20 obtained from £ * _ obtusus show that the enzyme is readily proteolyzed following cell ho ogenization, and that the partially proteolyzed enzyme is more heat labile than the intact enzyme.
  • proteolytic inhibitors such as phenyl ethylsufonyl fluoride (PMSF) and/or ethylenediamine tetraacetic acid (EDTA) .
  • PMSF phenyl ethylsufonyl fluoride
  • EDTA ethylenediamine tetraacetic acid
  • FIG. 1 The relative thermal stabilities of P. obtusus P20 isolated either in the presence or absence of proteolytic inhibitors is shown in FIG. 1.
  • a P20 preparation which is largely unproteolyzed loses only about 20% " of its total activity over a 90 minute incubation time at 65 ⁇ c, at pH 5.0, while the partially proteolyzed enzyme loses more than half its activity under similar conditions.
  • purified P. obtusus PD lost substantially all of its activity after 15 minutes of incubation at 65°C. Details of the heat-treatment studies are found in Example V.
  • the effect of heat-treating a P20 enzyme preparation under selected conditions can be determined by reacting the heat-treated enzyme with glucose under conditions substantially identical to those which have been described above with reference to FIGS. 3 and 3fi.
  • Example VI provides details of a reaction employing a heat-treated P20 preparation obtained from P. obtusus in the absence of protease inhibitors. The reaction products, fractionated by HPLC and monitored at 192 nm, gave the absorption profile seen in FIG. 3C_.
  • the yield and purity of the glucosone produced using the heat-treated enzyme is substantially improved over the results obtained using an untreated P20 preparation, and the improvement is expected to be still greater where protease inhibitors are added to the P20 preparation, and the length and/or temperature of the heating step is increased to produce greater inactivation of the pyranosone-utilizing enzyme(s).
  • the P20 obtained from P. obtusus is more resistant to heat inactivation than the P20 obtained from either C. versicnlor and L. betulinus.
  • the C. YgrsiCglor and L. betulinus P20 enzymes appear to be more protease-resistant. It can be appreciated that purification to remove enzyme contaminants would be preferred for protease-resistant P20 enzymes, whereas heat-treatment would be advantageous for more heat-resistant P20 enzymes.
  • the P20 preparation may be fractionated to remove product-utilizing enzymes and the purified P20 then used in a reaction which is carried out at pH 4.4.
  • Example IX describes such
  • a P20 enzyme which is substantially free of pyranosone-utilizing enzyme contaminants may be provided by selecting, as a source of the P20 enzyme, a
  • microorganism which is capable of converting glucose to glucosone, but is unable to convert glucose or glucosone to cortalcerone.
  • This selection procedure identifies microorganisms which synthesize P20 but little or no PD.
  • the organism is screened for the 0 ability to convert glucose to glucosone and glucosone to cortalcerone by conventional assay methods, such as those referred to above.
  • Example X describes specific procedures used in selecting two fungal organisms, £ * . yprsicolor and T . - h ⁇ - u_inus. which produce moderate 5 levels of P20, but which lack the ability to convert -23-
  • a purified or partially purified P20 enzyme is obtained from the selected source lacking measurable PD activity.
  • the P20 purification procedure comprises (1) obtaining a cell supernatant fraction containing the P20 enzyme, and (2) selectively precipitating the P20 with a protein-precipitating agent such as ammonium sulfate or polyethylene glycol.
  • the P20 enzyme may be further purified by chromatographic techniques, such as ion-exchange and/or molecular sieve chromatography.
  • Examples XI and XII below outline purification procedures used to obtain substantially pure P20 from C. versico.or and L. betulinus. respectively.
  • P20 obtained from L. betulinus was assayed for its ability to convert glucose to glucosone in a reaction containing 20 mM glucose, catalase, and oxygen, in a suitable buffer. After a two-hour reaction period, the products were fractionated by HPLC as monitored at 192 nm. Products analysis showed that the glucosone produced was substantially pure.
  • FIG. 4 presents, in flow-chart format, a general procedure for providing a P20 in accordance with the invention, based on the findings presented above.
  • the first step in the procedure is to identify microbial P20 producers, such as the three fungal sources of P20 discussed herein.
  • the organism may be carried through one or more mutation and selection steps, such as described in Example I, to produce strains which produce elevated levels of P20 and/or enhanced P20/PD ratios.
  • An especially advantageous strain obtained by mutagenesis and selection is P. obtusus strain AU124, cultures of which have been deposited at NRRL under No. 15595.
  • a partially purified P20 enzyme is obtained by batch purification techniques which preferably involve selective protein precipitation and centrifugation steps only. The partially purified P20 is then assayed for pyranosone-utilizing activity, e.g., by the ability of the enzyme preparation to convert glucose to substantially pure glucosone at about 6.0.
  • the preparation may be suitable for use as a "final" P20 enzyme in accordance with the invention.
  • the P20 preparation is obtained from a selected source such as C.- veriscolor or L. betulinus which does not show measurable PD activity on initial screening.
  • the contaminating enzyme activity is substantially eliminated by one or more of the three procedures described.
  • the enzyme preparation is utilized at a pH at which P20 activity is optimal or near-optimal, but at which pyranosone-utilizing enzyme(s) are largely inactive.
  • the P20 preparation is heat treated to inactivate pyranosone-utilizing enzymes preferentially. Both methods are suited to large-scale processes and are rapid and inexpensive, making them attractive for commercial-scale preparation of a P20 enzyme.
  • the P20 preparation can be further purified to remove product-utilizing enzyme contaminants.
  • PD is the major, if not the only. pyranosone-utilizing enzyme in the P. obtusus P20 enzyme preparation. Therefore, the purification method can focus on removal of PD only, simplifying the procedure.
  • Preparing Immobilized P2Q Reagent and Controtrlino Peroxide The conversion of a pyranose to the corresponding pyranosone by P20 in the presence of oxygen is accompanied by the stoichio etric production of H2O2.
  • the H2O2 produced in the reaction may promote oxidative degradation of the product.
  • the measured half-lives of P20 expressed in arbitrary half-life units are given in Example XIII, Table 1.
  • the presence of catalase, at a P20/catalase activity ratio of less than about 10-3 and preferably less than about 2 x 10-4 i.e., at an H2O2 concentration of less than about .2mM
  • the invention contemplates the use of a variety of peroxide-destroying catalysts to maintain the H2O2 concentration of the reaction medium at or below a desired level.
  • These reagents include enzymes, such as catalase, or metal catalysts, such as platinum.
  • a preferred catalyst includes catalase which has been freed of glucose-utilizing enzymes, such as glucose-1-oxidase, which are active in the pH 4.4 to 6.5 range.
  • the catalase may be obtained from conventional sources, such as Aspergillus nicer. Since P20 is both the site of H2O2 production, and a target of H2O2 inactivation, it is important to prevent locally high H2O2 transients, in the vicinity of the P20, as well as the buildup of H2O2 in the bulk phase.
  • the catalyst is preferably disposed in close physical association with the P20, preferably by coupling the P20 to a solid-support substrate having a surface-associated H2 ⁇ 2-decomposing catalyst. Intimate association between the oxidase enzyme and the catalyst on such a solid support is important particularly in a reactor system in which the medium is relatively unagitated, as in a packed reactor column.
  • a reagent constructed according to the invention includes a solid support and a surface array of molecules of P20 and an H2 ⁇ 2-deco posin catalyst.
  • the support may include a broad range of surface-treated or untreated organic and inorganic supports. Included among these are polyacrylamide, ethylene maleic acid copolymers, methacrylic-based polymers, polypeptides, styrene-based polymers, agarose, cellulose, dextran, silica, porous glass beads, charcoal, hydroxyapatite and aluminum or titanium hydroxide.
  • Methods for attaching enzymes and non-protein catalysts to solid supports include adsorbing the enzyme to the support, or coupling by covalent attachment.
  • a reagent containing both P20 and catalase is preferably formed by sequentially coupling catalase, then P20 to the support surface.
  • the H2O2 decomposing catalyst is an inorganic catalyst, such as platinum
  • the reagent preferably is formed as a catalyst-coated solid support to which the P20 is attached.
  • the activity ratio of P20 to catalyst in the reagent is selected to make the operation most cost effective.
  • factors to be considered are the relative costs of the P20 and catalyst, the efficiency of the reaction at different P20/catalyst activity ratios, the effect of H2O2 inactivation of the P20 and/or catalyst on the purity of the reaction product, and the purity and stability the product is required to have for the application(s) in which it is to be employed.
  • a P20/catalase activity ratio of about 10" 3 0 r less produces a relatively long P20 half-life in a continuous-reaction system.
  • a reaction carried out using the method of the invention may be performed in an unbuffered or weakly buffered solution, without periodic addition of base, over extended reaction periods.
  • a reaction in which glucose is converted to glucosone by a substantially pure P20, in the presence of purified catalase, without pH control, is described in Example XIV below.
  • the reaction, involving the conversion of a 6% solution of glucose to glucosone, is carried out for 3 hours at room temperature in an unbuffered aqueous medium at pH 5.0. The pH remained constant during the reaction. HPLC analysis of the reaction products indicate that the glucosone produced was about 99% pure. From the foregoing, several important advantages of the invention can be appreciated.
  • the method of the invention provides a significant improvement in purity and yield over prior art methods for converting a pyranose such as glucose to a pyranosone, such as glucosone.
  • P20 preparation can be provided without involved enzyme purification procedures. In two P20 preparation methods described herein, no chromatographic purification techniques are
  • purification may involve selective removal of a pyranosone dehydratase enzyme only.
  • the source of P20 selected is one which lacks the major, and perhaps only, pyranosone-utilizing enzyme, PD.
  • reaction can therefore be carried out over a several-hour period in an unbuffered reaction medium without addition of base.
  • a reagent constructed according to the invention includes a solid support having arrayed thereon molecules of P20 and H2 ⁇ 2 ⁇ removing catalyst, at an activity ratio between about 10"5 and 10" 3 .
  • This reagent has a half life which may be 30 to 60 times
  • This example describes the method used to produce a strain of P. obtusus which produces a level
  • the slant-grown organism was used to inoculate a yeast/malt extract medium and was grown for 7 days on a rotary shaker at 200 rpm, at room temperature. An inoculum from the liquid culture was regrown in yeast/malt extract medium under similar conditions.
  • the culture material was disrupted by blending at high speed in a blender at 4°C to break up mycelial filaments into small fragments, and these were plated out on yeast-malt extract agar plates. The plated colonies were transferred to liquid-medium growth flasks, and grown up under standard conditions. The cells were disrupted, and the contents of the cells assayed for the ability to convert glucose to glucosone. Glucosone production was determined using the triphenyltetrazolium chloride assay, which gives a strong colorimetric reaction in the presence of glucosone (Mattson, et al.. Anal. Chem. 22:182 (1950).
  • P. obtususus T strain cultures have been deposited by us at NRRL under No. 15594. They are also deposited at CMCC under No. 1421. The cultured T strain was washed in buffer and disrupted by blending, as above.
  • the disrupted culture material was added to a petri dish, in an amount just sufficient to cover the bottom of the dish, and irradiated with a General Electric 15W germicidal ultraviolet lamp for about 1-2 minute, while stirring the material rapidly with a magnetic stirrer to produce even irradiation of the cells.
  • the irradiation time and flux density were varied, the flux density by varying the distance between lamp and dish, to produce a survival rate of about 1-5%, based on number of colonies observed by agar plating before and after irradiation.
  • a culture of one mutagenized, high-producer strain selected from among the mutagenized cell material produced about five times as much P20, based on enzyme units per liter of culture material after six days, as that produced by the parental ATCC # 26733 strain.
  • Cultures of the high-producer strain, designated AU124 have been deposited at the NRRL, under No. 15595. Cultures of the strain are also deposited at CMCC under No. 1500.
  • the mycelia obtained from 400 ml of culture were washed twice with 0.05 M sodium phosphate buffer, pH 7.5, containing 10 mM EDTA and 50 ug/ml fresh phenylmethysulfonyl fluoride (PMSF) .
  • the mycelia were homogenized for 2 minutes in a Waring blender with 70 ml of 0.05 M sodium phosphate buffer pH 7.5, containing the above concentrations of protease inhibitors.
  • the homogenate was centrifuged at 6,000 rpm for 20 minutes and the supernatant, containing the P20 activity, was decanted and placed in a 500 Erlenmeyer flask. Polyethylene glycol was added to a final concentration of 19 grams per 100 ml.
  • the solution was stirred and then allowed to stand at 40 minutes at 4°C.
  • the precipitate was recovered by centrifugation at 10,000 rpm for 20 minutes.
  • the supernatant from the centrifugation step was decanted and discarded, and the pellet, containing the P20 enzyme activity, was resuspended by vortexing in 30 ml of 0.025 M sodium phosphate buffer, pH 7.5, containing 0.1 M sodium chloride and protease inhibitor(s) at the above-mentioned concentrations.
  • the purification was carried out as rapidly as possible at 4°C to minimize proteolysis of the P20 enzyme.
  • the suspension was allowed to stand for 30 minutes, during which time a precipitate formed, then centrifuged at 10,000 rpm for 20 minutes.
  • the resulting clear, yellow supernatant had a specific activity of about 4 units per milligram of protein, as compared with about 0.5 units per milligram of protein in the supernatant fluid of the crude, cleared lysate.
  • the enzyme so obtained is also referred to herein as a partially-purified P20 enzyme preparation.
  • the P20 enzyme preparation was tested for its ability to convert substantially pure glucose to -35-
  • glucosone at pH 6.0 in the presence of oxygen and catalase was a highly purified A__ ni ⁇ er catalase obtained from Fermco, Inc. (Elk Grove, Illinois) (Lot No. 4927, 154 ⁇ /mg) .
  • Glucose-1-oxidase contaminants in the catalase were removed by purification using DEAE chromatography.
  • One gram of catalase was purified by elution from a 5 x 12 cm column using a 0-150 mM NaCl gradient in 20 mM sodium acetate (pH 4.7). The bulk of the catalase activity eluted in a peak which was well separated from glucose-1-oxid ⁇ se activity.
  • Catalase was monitored by absorption of its heme group at 404 mM.
  • the P20 enzyme preparation from Example II was purified further using DEAE chromatography in 30 mM TRIS-HCl, pH 8.5, containing 2 mM EDTA and 10 ug/ml -36-
  • the sample was further purified by molecular sieve chromatography using a 1.5 x 95 cm Biogel P300 column in 100 mM sodium phosphate, pH 7 buffer.
  • the P20 activity eluted at a sharp peak corresponding to an apparent native molecular weight of about 290,000 daltons.
  • the purity of the P20 fraction which eluted from the P300 column was examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) , according to a standard procedure.
  • the P20 sample showed a single band having a migration distance corresponding to a molecular weight of about 68,000 daltons.
  • the enzyme was judged to be about 98% pure, based on the relative intensity of the faint contaminant protein bands with respect to the major band corresponding to P20 subunit.
  • the purified P20 enzyme had a specific activity of about 8.6 units per milligram, representing an approximately 22-fold purification over the activity of P20 seen in cleared lysates.
  • the amount of enzyme recovered was about 40% of the total starting material.
  • the approximate 290,000 dalton molecular weight of the native P20 enzyme and its approximate 68,000 subunit molecular weight suggest that the protein is a homotetramer.
  • the enzyme appears to contain one covalently bound flavin molecule per subunit (detectable as UV-fluorescence in the 68,000 dalton SDS-PAGE band) , and has absorption maxima at 276, 357 and 456 nm.
  • the enzyme has a sedimentation coefficient of about 11.4, as determined by sucrose gradient ultracentrifugation.
  • the relative activities of the enzyme, on D-glucose, L-sorbose, D-xylose, and D-gluconolactone are 100: 80: 48: 12, respectively, at about 1% (w/v) substrate concentration.
  • the enzyme has a broad pH optimum of between about 4.5 and 5.5.
  • the purified P20 obtained in accordance with Example III was used to convert glucose to glucosone in a reaction substantially identical to that described in Example II. Briefly, 0.46 International Units of the enzyme were mixed in a 0.5 ml reaction medium containing 2% glucose in 0.1 M sodium phosphate, pH 6.0, and purified catalase. The reaction was performed at 25 ⁇ c in the presence of air, at 90% relative humidity, for 6 hours. The reaction products were analyzed by HPLC, with the material eluted being monitored by ultraviolet light absorption at 192 mm. The absorbance profile of the material produced in the reaction is shown in FIG. 3fi. Here it is seen that substantially all of the material produced is in the prominent peak identified as glucosone, with very little by-product material being formed. A comparison of FIGS. 3fi and 3 ⁇ shows the importance of removing glucosone-utilizing enzyme contaminants, including primarily, if not solely, PD, in improving both the yield and purity of the glucosone produced by P20.
  • Example V Heat-treating the P20.enzyme preparation
  • a P20 enzyme preparation was prepared from P. obtusus AU124 substantially in accordance with the method described in Example II.
  • the P20 enzyme in the preparation was substantially unproteolyzed by virtue of the protease inhibitors used during the preparation steps.
  • a second P20 enzyme preparation studied was prepared in substantially the same way, except that no protease inhibitor was used in any of the preparation steps.
  • the P20 of this preparation was purified substantially to homogeneity, it was found to have variable subunit molecular weights, principally molecular weights of about 65,000 daltons, 34,000 daltons, 30,000 daltons, and approximately 4,000 daltons, indicating partial proteolysis of the enzyme.
  • Heat-treatment of each enzyme preparation was carried out at pH 5.0 in 50 mM sodium citrate, 1 mM EDTA, at 65°C.
  • the P20 activity in each preparation was measured at the beginning of the heat-treatment and after 15, 30, 60 and 90 minutes of heating at 65°C.
  • P20 activity was determined at 25°C by oxygen consumption in the presence of glucose, using an oxygen electrode according to known methods.
  • FIG. 1 it is seen that P20, which is largely unproteolyzed ,loses less than about 10% of its activity after incubation at 65°C for 15 minutes, and about 20% of its original activity after 90 minutes of heat-treatment.
  • the partially proteolyzed P20 loses about 30% of its activity in the first 15 minutes and more than half of its activity after 90 minutes of heating.
  • PD was removed from the nonproteolyzed P20 enzyme fraction and purified substantially to homogeneity. Briefly, the PEG-precipitated P. obtusus P20 enzyme preparation was fractionated using DEAE chromatography, pH 8.5. The PD enzyme was identified y its ability to convert glucosone to products having optical absorption at 230 and 265 nm. To remove minor contaminants, the column fractions containing maximal PD activity were rechromatographed on a smaller DEAE column, using the same conditions.
  • Peak enzyme fractions from the second DEAE column were further purified on a carboxymethyl sepharose column (Pharmacia CL-6B) and eluted therefrom, at pH 5.5, by a 0-200 mM NaCl gradient in 50 mM sodium acetate, pH 5.5.
  • the resulting partially purified PD was diluted into 50 mM sodium acetate, pH 5.0, containing 1 mM EDTA and a small amount of purified P. obtusus P20 and heat-treated at 65°C for time intervals ranging from 5 minutes to 30 minutes.
  • the partially proteolyzed P20 enzyme preparation from Example V was heat-treated, at pH 5.0, for 15 minutes at 65°C.
  • the heat-treated fraction was reacted with 2% glucose under conditions identical to those described in Example II.
  • the reaction products were separated by HPLC and monitored at 192 nm, with the results seen in FIG. 3£. It can be seen from a comparison of FIGS. 3£ and 3 ⁇ that heat-treating the P20 enzyme preparation produced a substantial increase in the yield of glucosone, and a corresponding decrease in by-products.
  • Example VII P. obtusus P20 and PD pH Profiles; Molecular Weight of PD P20 and PD from P. obtusus. strain AU124, were isolated in accordance with the methods described in Examples III and V, respectively.
  • the activity of the P20 enzyme as determined by the rate of O2 consumption in the presence of glucose, was measured over a pH range from about 3.0 to 7.0.
  • the pH profile of P20 indicated by the dashed line in FIG. 2, shows that the enzyme pH optimum is between 4.5 and 5.5.
  • the pH profile of the purified PD as determined by its ability to convert glucosone to the product which absorbs at 265 nm, was measured over a pH range from about 4.0 to 10.0.
  • the PD pH profile indicated in solid lines in FIG. 2, shows that the enzyme has a pH optimum of about 7.5, and displays less than about 5% of its optimal activity when assayed at pH 4.4.
  • PD-containing fractions with peak activity eluted from the carboxymethyl sepharose column as described in Example V were pooled and concentrated to 0.5 ml, using Amicon PM30 ultra-filtration, and then sized according to native molecular weight by molecular sieve chromatography using a 1.5 x 95 cm Biogel P300 column, with 100 mM sodium phosphate buffer, pH 7.0.
  • PD activity eluted as a sharp peak at an apparent native molecular weight of about 200,000 daltons.
  • PD was further analyzed by SDS-PAGE according to a standard procedure. The sample showed a single band with molecular weight of about 98,000 daltons. PD from P. obtusus is thus apparently composed of two identical subunits.
  • the enzymatic conversion of glucose to glucosone by the partially purified P20 enzyme preparation from Example II at pH 4.4 was studied.
  • the reaction conditions were substantially identical to those described in Example II, except that the reaction was carried out at pH 4.4, using a 0.1 M sodium citrate buffer rather than the 0.1 M sodium phosphate buffer used for the pH 6.0 reactions described in Examples II, IV and VI.
  • the reaction products were analyzed by HPLC, and monitored at 192 nm, with the results shown in FIG. 3 ⁇ .
  • the pH remained substantially unchanged over the 6 hour reaction period. As seen from the absorbance profile in FIG. 3Q, performing the reaction at pH 4.4 leads to a very high yield and purity of glucosone, and almost complete suppression of by-products formed in the reaction.
  • Example VII It was seen in Example VII above that the PD enzyme contained in the P. obtusus P20 enzyme preparation is largely inactive at pH 4.4.
  • the fact that by-product formation is largely suppressed at pH 4.4 indicates that (1) PD is the major, if not sole, glucosone-utilizing enzyme contaminant in the P20 enzyme preparation and/or (2) the PD pH profile, and particularly its low activity at pH below about 4.4, is typical of other glucosone-utilizing enzyme contaminants in the P20 preparation.
  • Glucosone production with purified P20 at pH 4.4 The present example demonstrates the high product yield and purity achievable in a glucose-to-glucosone reaction using a substantially purified P20 enzyme and carrying out the reaction at pH 4.4.
  • the reaction conditions used were substantially those used in Example VIII, except that P20 enzyme derived from P. obtusus AU124 and purified in accordance with Example III was used instead of the partially purified P20 enzyme preparation from Example II.
  • the products were analyzed by HPLC, as monitored at 192 nm, with the results shown in FIG. 3£. The results indicate that substantially no by-products were formed during the 6 hour reaction period.
  • the purity of glucosone produced in the reaction was estimated to be greater than 99%, based on the relative peak areas of glucosone and by-products.
  • This example illustrates another embodiment of the method of the invention for providing a P20 enzyme which is substantially free of pyranosone-utilizing enzyme contaminants at a selected pH between about 4.4 and 6.5. .
  • a number of fungal species have been found to be capable of converting glucose to glucosone. These include Aspergillus flavus (C. Berkeley, Biochem. J. 21, 1357 (1933); Aspergillus parasiticus (C. Berkeley, Biochem. J. 11, 1033 (1937); Polyporus obtusus (Janssen and Ruelius (1968), supra); Corticiu ⁇ . caeruleurn (Baute, et al. (1977), Slipra) ; and Oudemansiella muojda (Vole, et al.. Coll Czech. Chem. Commun. 15, 950 (1980).
  • the ability of a microorganism to convert glucose to glucosone presumably requires that the microorganism possess an enzyme or enzyme system with glucose-2-oxidase activity.
  • the P. obtusus and £_». mucida species have been shown to have an enzyme or enzyme system with pyranose-2-oxidase activity.
  • Glucose-2-oxidase activity and by implication pyranose-2-oxidase activity, are not found in all fungal species, even in all white-rotting fungal species, and apparently not even in all species of any fungal genus which has at least one species which has glucose- or pyranose-2-oxidase activity.
  • 163 fungal strains including the following 13 white-rotters:
  • F4 agar consists of 5.0 g tryptone, 3.0 g malt extract, 10.0 g glucose, 3.0 g yeast extract and 0.2 g agar combined with 1.0 1 of distilled water (£ ⁇ a Pansey, et al. Antimicrob. Agents Chemotherapy, 399 (1966).
  • FA agar is prepared by combining 15.0 g glucose, 3.0 g yeast extract, 1 ml artificial sea water (from Aquarium systems Inc., Eastlake, Ohio) and 0.2 g agar with 966 ml of distilled water (See v. Lilly and H. Barnett, Physiology of the Fungi. McGraw-Hill Book Co., Inc., New York, New York (1951)), then autoclaving the mixture for 15 minutes at 15 psi pressure, and finally adding 100 microgra s thia ine and 5 microgram biotin via filter sterilization. Cultures on both of the agars were grown and assayed in the same manner, as follows.
  • a culture was inoculated into the approximately 3 ml of agar, in a capped sterile vial, by picking the slant culture on which the strain was received and stored, with a sterilized toothpick and then asceptically touching the tip of the toothpick to the surface of the agar pad approximately at its center. Growth was continued for 2 to 4 days at 25°C, as long as required for the organism to cover the agar pad. All of the above-listed 13 white-rotter strains were grown for 4 days.
  • 5.0 ml of sterile 2% (w/v) glucose solution was introduced asceptically into the vial; and the vial was then shaken at 250 rpm for 24 hours at 25 ⁇ c After the shaking, 1.0 ml of fluid was removed from the vial and immediately processed for testing for the presence of glucosone.
  • the first step in the processing was to add to the 1.0 ml of fluid 0.2 ml of a solution of 2% (w/v) 2,4-dinitrophenylhydrazine in 30% perchloric acid.
  • TLC thin-layer chromatography
  • the TLC assay could detect glucosone from a culture if as little as 0.08% of the glucose in the culture system (after addition of the 2% glucose solution just prior to the 24-hour shaking) was present as glucosone at the time the 2,4-dinitrophenylhydrazine was added to the 1.0 ml of culture removed for assay.
  • a finding of detectable glucosone in the assay of a culture indicted the fungal strain in the culture had a glucose-2-oxidase activity of potential commercial valve.
  • the same assay technique could have been used with xylose instead of glucose to detect xylose-2-oxidase activity via the formation of the hydrazone of xylosone.
  • the cultured cells were plated on agar plates and selected for high producers of P20, substantially as described in Example I, leading to cultures of substantially uniform, relatively high producers.
  • the best culture found produced P20 at a yield, expressed in International Units per liter of growth medium, after 6 days of incubation, which was approximately 30% that produced by the above-identified P. obtusus strain AU124. This best culture of C.
  • Example XI Preparation and Characterization of C. versicolor P20
  • the high-producer culture of C. versicolor described in Example X was grown in submerged culture in 1.5 liters of yeast/malt extract medium at 28oc for 7 days.
  • the resulting mycelial balls were collected by filtration, washed, and then disrupted at 4 ⁇ in 50 mM sodium phosphate, pH 7.0, for 3 minutes using an Ultraturrax blender.
  • the lysate was cleared by centrifugation 25 minutes at 12,000 rpm.
  • solid ammonium sulfate was slowly added to 55% saturation, and the solution was allowed to stand for 90 minutes at 40C, prior to collecting the precipitate.
  • the precipitate was resuspended in 42 ml of 30 mM TRIS-HCl, pH 8.5, dialyzed against the same buffer, and centrifuged at 10,000 rpm for 15 minutes to remove a precipitate.
  • the enzyme was applied to a 2.6 x 40 cm DEAE column, washed, and eluted using a 0-300 mM NaCl gradient.
  • the P20 elutes at about 220 mM. Portions of each fraction were assayed for P20 activity, by monitoring peroxide generation conventionally. Protein concentration was also determined by a conventional method.
  • the fractions containing P20 activity were pooled and concentrated by ultrafiltration with an Amicon PM10 filter obtained from Amicon Corp. Peak fractions were dialyzed into 30 mM sodium acetate (pH 5.5) , adjusted to 1.5M NaCl and loaded onto a phenylsepharose column.
  • the P20 was eluted with a 0-1.5 M NaCl gradient in 50 mM sodium acetate, pH 5.5.
  • the enzyme eluted at about 1.1 M NaCl.
  • Fractions containing the peak activity were pooled and concentrated to 0.5 ml by Amicon PM30 ultrafiltration and sized according to native molecular weight using a 1.5 x 95 cm Biogel P300 column. Elution was at 0.1 ml/minute with 100 mM sodium phosphate, pH 7.0.
  • the enzyme's apparent native molecular weight was calculated to be about 130,000 daltons.
  • a single band having a molecular weight of about 65,000 was Observed when the enzyme was analyzed by SDS-PAGE. The enzyme thus appears to be a homodimer.
  • the enzyme was judged to be about 95% pure, based on the staining intensity of protein bands in SDS-PAGE.
  • the protein has absorption maxima at 276, 357 and 454 nm.
  • the relative activities of the enzyme on the substrates D-glucose, L-sorbose, D-xylose and delta-D-gluconolactone are 100: 74: 41: 6, respectively, at 1% (w/v) substrate concentration.
  • the enzyme has a pH optimum of about 5.0.
  • Example XII Preparation and characterization of P20 from L. betulinus
  • the high-producer culture of ⁇ .. betulinus described in Example X was grown according to the conditions described in Example II.
  • the cells were homogenized and centrifuged to produce a supernatant, also in accordance with the methods described in Example II.
  • Polyethylene glycol was added to the supernatant to a final concentration of 20%, and the mixture was allowed to stand for 2 hours at 4 ⁇ c, producing a precipitate which was pelleted " by centrifugation.
  • the resulting clear yellow supernatant was further purified using DEAE chromatography in 30 mM TRIS-HCl, pH 8.5, and eluted from the 5 x 16 cm column using a 0-300 mM NaCl gradient. The protein eluted at about 75 mM NaCl. Fractions containing the peak of P20 activity were pooled and concentrated to 0.5 ml by Amicon PM30 ultrafiltration, and then fractionated, according to native molecular weight, using a 1.5 x 95 cm Biogel P300 column. The column was run at a flow rate of 0.1 ml per minute, using 100 mM sodium phosphate, pH 7.0.
  • the protein eluted in a fraction corresponding to an apparent native molecular weight of about 300,000 daltons. Analysis of the purified protein by SDS-PAGE showed one major band corresponding to a molecular weight of about 65,000 daltons, and minor bands, presumably representing impurities. Based on the molecular weight data, the protein appears to be a homotetramer.
  • the enzyme contains a covalently attached flavin on each subunit, and has absorption maxima at 275, 360, and 450 nm.
  • the relative activities of the purified enzyme on the pyranose substrates D-glucose, L-sorbose, D-xylose and delta-D-gluconolactone are 100: 43: 43: 26, respectively, at 20 mM substrate concentration.
  • the enzyme has a broad pH optimum between about 5 and 6.
  • a P20 enzyme preparation was derived from P_»_ nhtusus AU124 in accordance with the method detailed in Example II.
  • A- nig_-r catalase was obtained from Fermco, Inc., and further purified by DEAE ion-exchange chromatography to remove glucose-1-oxidase activity present in the commercially available enzyme, as in Example II.
  • Reagents containing the various activity ratios of P20 to catalase shown in Table I were prepared by sequential adsorption of first catalase and then P20 to the support.
  • the activity ratios of P20 to catalase in the four supports is the theoretical steady-state level of H2O2 in moles per liter expected in a P20-reaction, assuming no inactivation of either enzyme.
  • Each of the supports was packed in a 7 mm x 1.2 M glass Pyrex column reactor by pouring a slurry of the support over about 10 inches of 1 mm diameter non-porous glass beads, and applying a low vacuum to the bottom to aid in settling the bed.
  • a packed column height of 25 inches was reached, another 10 inches of glass beads was placed on the resin bed followed by approximately an inch of glass wool.
  • the column was equilibrated with 25 mM citrate, pH 5.5.
  • the reaction was started up by introducing a 5% solution of glucose in citrate buffer through the column.
  • the level of H2O2 which eluted from the reactor column was monitored over a period of continuous column operation of about 12 days.
  • the reactor packed with reagent #2 showed a steady increase in H2O2 concentration from a level of about 0.3 to 3 mM, over the first four to five days of reactor operation, indicating a slow inactivation of catalase, presumably by the H2O2 being produced in the P20 reaction. From the maximum concentration of about 3 mM, the H2O2 concentration declined gradually to about 0.3 mM by the twelfth day of reactor operation. For both reagents #3 and #4, the reactor H2O2 concentration started from initial levels at or below about 0.3 mM, and remained substantially constant over a several day reaction period, and then showed increases of up to about 0.7 mM and 0.3 mM, respectively, by the twelfth day of the reaction.
  • H2O2 concentrations in the four reactors measured after three days of column operation, are listed in the third column in Table I.
  • the measured concentrations of H2O2 are consistent with the theoretical H2O2 concentrations calculated from the associated P20 to catalase activity ratios.
  • the half-life of the P20 enzyme was determined by monitoring the rate of glucosone production in the corresponding reaction during the 12-day course of the reaction. Glucosone levels produced by each reactor were measured using the above-described triphenytetrazolium colorometric assay for glucosone. The half-life data are shown at the right-hand column in Table I.
  • the actual half-life values have been normalized to an arbitrary unit value of 1 for the reagent #1 lacking catalase.
  • the data show that the half-life of P20 is increased about 11- fold by employing a P20 to catalase ratio which maintains the H2O2 concentration below about 3 x lO -4 M (reagent #3) and can be increased between about 28 and 60 fold by employing a P20 to catalase activity ratio which maintains the H2O2 concentration in the reactor below about 4 x 10"5M.
  • Example XIV Production of substantially pure glucosone
  • the enzyme was used to convert glucose to glucosone under the following conditions:
  • the purified P20 (0.46 ' units) and catalase were added to 500 microliters of unbuffered medium, pH 5.0.
  • Glucose was added to a final concentration of about 5%.
  • the reaction was carried out at room temperature, under 90% relative humidity, until all of the glucose substrate was consumed.
  • the pH of the solution remained constant at 5.0 throughout the reaction period without the addition of a base to the reaction mixture.
  • reaction products were analyzed by HPLC, monitored at 192 nm, as described in Example IV.
  • the absorption profile of the HPLC-fractionated products is shown in FIG. 5.
  • the glucosone was judged to be greater than 99% pure, based on the relative areas of the peaks associated with glucosone and reaction by-products.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP86900945A 1986-01-16 1986-01-16 Verfahren und pilzstämme zur herstellung von pyranoson Withdrawn EP0262118A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/000082 WO1987004460A1 (en) 1986-01-16 1986-01-16 Methods and fungal strains for pyranosone production

Publications (1)

Publication Number Publication Date
EP0262118A1 true EP0262118A1 (de) 1988-04-06

Family

ID=22195337

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86900945A Withdrawn EP0262118A1 (de) 1986-01-16 1986-01-16 Verfahren und pilzstämme zur herstellung von pyranoson

Country Status (2)

Country Link
EP (1) EP0262118A1 (de)
WO (1) WO1987004460A1 (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58209980A (ja) * 1982-04-27 1983-12-07 Kyowa Hakko Kogyo Co Ltd 酵素の精製法
US4440855A (en) * 1982-06-30 1984-04-03 Nabisco Brands, Inc. Process for preparing L-glucosone
US4442207A (en) * 1982-06-30 1984-04-10 Nabisco Brands, Inc. Process for production of glucosone
EP0119332B1 (de) * 1983-03-11 1988-05-25 Kyowa Hakko Kogyo Co., Ltd. Pyranose-Oxydase, Verfahren zur Herstellung und Anwendung derselben und dazu verwendbare Testzusammensetzungen
US4568645A (en) * 1984-02-24 1986-02-04 Cetus Corporation Fungal pyranose-2-oxidase preparations
US4569915A (en) * 1984-02-24 1986-02-11 Cetus Corporation P. obtusus strain
US4569910A (en) * 1984-02-24 1986-02-11 Cetus Corporation Methods and reagents for pyranosone production
US4569913A (en) * 1984-02-24 1986-02-11 Cetus Corporation P. obtusus pyranose-2-oxidase preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8704460A1 *

Also Published As

Publication number Publication date
WO1987004460A1 (en) 1987-07-30

Similar Documents

Publication Publication Date Title
Kelley et al. Purification and characterization of glucose oxidase from ligninolytic cultures of Phanerochaete chrysosporium
US4727026A (en) Method for direct saccharification of raw starch using enzyme produced by a basidiomycete belonging to the genus Corticium
FI69314B (fi) Foerfarande foer framstaellning av fruktos
US4569913A (en) P. obtusus pyranose-2-oxidase preparation
US4442207A (en) Process for production of glucosone
EP0194760B1 (de) Xylose-Isomerase, Verfahren zur Herstellung dieser Xylose-Isomerase, immobilisierte Xylose-Isomerase und Verfahren zum Isomerisieren von Glukose zu Fruktose
EP0639645A1 (de) Verfahren zur Herstellung von Trehalose
US4770997A (en) Thermostable bilirubin oxidase and production process thereof
US4569915A (en) P. obtusus strain
US4321323A (en) Carbohydrate process
US4569910A (en) Methods and reagents for pyranosone production
US4677062A (en) Process for producing bilirubin oxidase
US4568645A (en) Fungal pyranose-2-oxidase preparations
JP3086301B2 (ja) L−グロノ−ガンマ−ラクトン脱水素酵素
EP0219673B1 (de) Verfahren zur Herstellung einer thermostabilen Transglucosidase
US4283496A (en) Preparation and use of glucose isomerase
US4707446A (en) Stable haloperoxidase method
US4061539A (en) Preparation and use of glucose isomerase
WO1987004460A1 (en) Methods and fungal strains for pyranosone production
US5116752A (en) Process for preparing neuraminidase
WO1981003666A1 (en) Process for making fructose
CA1261289A (en) Peroxidase and a process of its preparation
US4937191A (en) Stable haloperoxidase method
CA1160170A (en) Uricase production method
EP1476544A1 (de) Enon reduktase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19871019

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RING, DAVID, B.

Inventor name: FERNANDES, PETER, M.

Inventor name: KOTHS, KIRSTON, E.

Inventor name: HALENBECK, ROBERT, F.